Consideration of sense of coherence in a structured communication approach with stage IV lung cancer patients and their informal caregivers: a qualitative interview study.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 27 05 2020
accepted: 26 08 2020
pubmed: 4 9 2020
medline: 20 3 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

Salutogenetic aspects are valuable for consideration in patient-centred care of advanced oncological diseases with a limited life expectancy. The Milestone Communication Approach (MCA), involving physician-nurse tandems, addresses specific challenges and needs over the disease trajectory of patients with stage IV lung cancer and their informal caregivers. This study aims to explore patients' and informal caregivers' salutogenetic experiences with the MCA concept. This qualitative study used face-to-face semi-structured interviews with patients and informal caregivers. All generated data were audio-recorded, pseudonymised and transcribed verbatim. Data were structured using Qualitative Content Analysis. The material was coded deductively into themes related to the components of sense of coherence (Aaron Antonovsky) and emerging sub-themes. All data was managed and organised in MAXQDA. In 25 interviews, sense of coherence was referred to with all three components: "Comprehensibility" was supported by information conveyed suitably for the patients; "meaningfulness" was addressed as accepting the situation; and "manageability" led to advance care planning the patients were comfortable with. Patients and informal caregivers experienced the interprofessional tandem as an added value for patient care. Participants appreciate the MCA in its support for coping with a life-limiting disease. Considering salutogenetic aspects facilitates prognostic awareness and advance care planning. Nevertheless, individual needs of patients and informal caregivers require an individualised application of the MCA.

Identifiants

pubmed: 32880008
doi: 10.1007/s00520-020-05724-2
pii: 10.1007/s00520-020-05724-2
pmc: PMC7892692
doi:

Types de publication

Interview

Langues

eng

Sous-ensembles de citation

IM

Pagination

2153-2159

Subventions

Organisme : Bundesministerium für Gesundheit
ID : ZMV I1 - 2517 FSB 001
Organisme : Nationales Centrum für Tumorerkrankungen Heidelberg
ID : NCT 3.0, G835

Références

Pneumologie. 2015 Feb;69(2):79-85
pubmed: 25668607
Psychooncology. 2016 Jan;25(1):2-10
pubmed: 25787699
BMC Palliat Care. 2020 Feb 18;19(1):21
pubmed: 32070311
Psychooncology. 2019 Jan;28(1):54-60
pubmed: 30286514
Camb Q Healthc Ethics. 2012 Jan;21(1):20-9
pubmed: 22152455
Eur J Oncol Nurs. 2020 Feb;44:101693
pubmed: 31783326
Braz Oral Res. 2020 Feb 07;34:e009
pubmed: 32049110
Oncol Nurs Forum. 2014 Mar 1;41(2):E44-55
pubmed: 24578085
Eur J Oncol Nurs. 2016 Apr;21:153-9
pubmed: 26467922
Eur J Oncol Nurs. 2011 Sep;15(4):339-46
pubmed: 20951090
Trials. 2018 Aug 14;19(1):438
pubmed: 30107809
Sociol Health Illn. 2017 Nov;39(8):1448-1464
pubmed: 29044627
J Pain Symptom Manage. 2007 Oct;34(4):370-9
pubmed: 17616335
Oncol Res Treat. 2019;42(1-2):41-46
pubmed: 30677754
ERJ Open Res. 2018 May 18;4(2):
pubmed: 29796390
BMJ Open. 2019 Feb 5;9(2):e020515
pubmed: 30813114
Psychooncology. 2013 Jan;22(1):20-7
pubmed: 21910162
J Clin Oncol. 2018 Jan 1;36(1):53-60
pubmed: 29140772
J Health Psychol. 2011 Mar;16(2):249-57
pubmed: 20929943
Palliat Med. 2019 Dec;33(10):1310-1318
pubmed: 31368844
Contemp Oncol (Pozn). 2019;23(3):157-163
pubmed: 31798331

Auteurs

Katja Krug (K)

Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. katja.krug@med.uni-heidelberg.de.

Jasmin Bossert (J)

Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
Thoraxklinik Heidelberg, Department of Thoracic Oncology, Heidelberg University Hospital, Röntgenstraße 1, 69126, Heidelberg, Germany.

Lydia Stooß (L)

Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Anja Siegle (A)

Thoraxklinik Heidelberg, Department of Thoracic Oncology, Heidelberg University Hospital, Röntgenstraße 1, 69126, Heidelberg, Germany.

Matthias Villalobos (M)

Thoraxklinik Heidelberg, Department of Thoracic Oncology, Heidelberg University Hospital, Röntgenstraße 1, 69126, Heidelberg, Germany.

Laura Hagelskamp (L)

Thoraxklinik Heidelberg, Department of Thoracic Oncology, Heidelberg University Hospital, Röntgenstraße 1, 69126, Heidelberg, Germany.

Corinna Jung (C)

Thoraxklinik Heidelberg, Department of Thoracic Oncology, Heidelberg University Hospital, Röntgenstraße 1, 69126, Heidelberg, Germany.
Medical School Berlin, Calandrellistr. 1-9, 12247, Berlin, Germany.

Michael Thomas (M)

Thoraxklinik Heidelberg, Department of Thoracic Oncology, Heidelberg University Hospital, Röntgenstraße 1, 69126, Heidelberg, Germany.

Michel Wensing (M)

Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH